This single center study will help determine the absorption, metabolism, and excretion of LBH589 and to assess the safety and efficacy of LBH589 in advanced cancer patients for whom no standard therapy exists.

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

An Open-label, Single Center, Study to Determine the Absorption, Distribution, Metabolism, and Excretion (ADME) of LBH589 After a Single Oral Administration of 20 mg (14C) LBH589 in Advanced Cancer Patients

Treatment Trials

Focus your search

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Description

Conditions